Repository logo
 

ULK1-mediated phosphorylation of ATG16L1 promotes xenophagy, but destabilizes the ATG16L1 Crohn's mutant.

Accepted version
Peer-reviewed

Type

Article

Change log

Authors

Alsaadi, Reham M 
Tian, Wensheng 
Jackson, Anne 
Guo, Zhihao 

Abstract

Autophagy is a highly regulated catabolic pathway that is potently induced by stressors including starvation and infection. An essential component of the autophagy pathway is an ATG16L1-containing E3-like enzyme, which is responsible for lipidating LC3B and driving autophagosome formation. ATG16L1 polymorphisms have been linked to the development of Crohn's disease (CD), and phosphorylation of CD-associated ATG16L1 T300A (caATG16L1) has been hypothesized to contribute to cleavage and autophagy dysfunction. Here we show that ULK1 kinase directly phosphorylates ATG16L1 in response to infection and starvation. Phosphorylated ATG16L1 localizes to the site of internalized bacteria and stable cell lines harbouring a phospho-dead mutant of ATG16L1 have impaired xenophagy, indicating a role for ATG16L1 phosphorylation in the promotion of anti-bacterial autophagy. In contrast to wild-type ATG16L1, ULK1-mediated phosphorylation of caATG16L1 drives its destabilization in response to stress. In summary, our results show that ATG16L1 is a novel target of ULK1 kinase and that ULK1 signalling to ATG16L1 is a double-edged sword, enhancing the function of the wild-type ATG16L1, but promoting degradation of caATG16L1.

Description

Keywords

ATG16L1, Crohn's disease, ULK1, autophagy, caspase

Journal Title

EMBO Rep

Conference Name

Journal ISSN

1469-221X
1469-3178

Volume Title

Publisher

Springer Science and Business Media LLC

Rights

All rights reserved
Sponsorship
Wellcome Trust (095317/Z/11/Z)
Wellcome Trust (100140/Z/12/Z)
This work was supported by Canadian Institutes of Health Research (CIHR) Project Grants awarded to RCR (#PJT153034), the UK Dementia Research Institute (funded by MRC, Alzheimer’s Research UK and the Alzheimer’s Society), Wellcome Trust (Principal Research Fellowship to DCR (095317/Z/11/Z), Strategic Grant to Cambridge Institute for Medical Research (100140/Z/12/Z) and studentship to AJ, and the Roger de Spoelberch Foundation. Accademic scholarship from the government of Saudi Arabia (#5976670433) and studentship supported RA. TTL was supported by an Ontario Graduate Scholarship.